Premium
Nutcracker oesophagus: a double‐blind, placebo‐controlled, cross‐over study of the effects of lansoprazole
Author(s) -
Borjesson M.,
Rolny P.,
Mannheimer C.,
Pilhall M.
Publication year - 2003
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1046/j.1365-2306.2003.01788.x
Subject(s) - medicine , lansoprazole , placebo , reflux , gastroenterology , chest pain , pathophysiology , pathology , omeprazole , alternative medicine , disease
Summary Background : Nutcracker oesophagus is characterized by high‐amplitude oesophageal contractions. Recent data have shown a high prevalence of gastro‐oesophageal acid reflux in patients with nutcracker oesophagus and, in open‐label trials, patients seemed to benefit from acid suppression. Therefore, it has been suggested that non‐cardiac chest pain in patients with nutcracker oesophagus may be related to reflux rather than to the motor abnormality itself. Aims : To investigate the effect of intensive acid‐suppressive treatment on chest pain in patients with nutcracker oesophagus. Methods : Nineteen patients with nutcracker oesophagus received lansoprazole or placebo in a double‐blind, randomized, cross‐over study. Results : Significant reductions in pain intensity ( P < 0.006) and pain duration ( P < 0.05) were registered during the study. The magnitude of symptom relief achieved with lansoprazole did not differ significantly from that achieved with placebo. The motility pattern did not change during the study. Conclusions : This study does not prove that acid‐suppressive therapy is effective for pain relief in nutcracker oesophagus. As the amelioration of pain was not accompanied by any change in the nutcracker oesophagus pattern, it is unlikely that the high‐amplitude oesophageal contractions are the cause of pain. Thus, the possible role of acid in the pathophysiology of pain in nutcracker oesophagus needs further study.